As of Jul 31
| -0.46 / -0.34%|
The 22 analysts offering 12-month price forecasts for Vertex Pharmaceuticals Inc have a median target of 145.00, with a high estimate of 180.00 and a low estimate of 85.00. The median estimate represents a +7.41% increase from the last price of 135.00.
The current consensus among 26 polled investment analysts is to Hold stock in Vertex Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.